Medicine
Januvia 100 mg tablet
Januvia 100 mg tablet is a prescription medicine containing Sitagliptin for oral use, marketed by Merck Sharp & Dohme, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20-25°C (68-77°F), excursions permitted to 15-30°C (59-86°F).
Key facts
- Active ingredient (INN)
- Sitagliptin
- Brand
- Januvia
- Strength
- 100 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 2 blister pack, 100 blister pack and 8 more
- Marketing authorisation holder
- Merck Sharp & Dohme
- Manufacturers
- Merck Sharp & DohmeA-S Medication SolutionsCardinal Health
- Origin register
- US FDA, United States
- Storage
- Store at 20-25°C (68-77°F), excursions permitted to 15-30°C (59-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BH01 Sitagliptin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 October 2006
- Identifiers
- RxCUI 665036, 665040, 665044 +3DailyMed set ID f85a48d0-0407-4c50-b0fa-7673a160bf01, 9d558f96-24a5-4788-8933-38256c17384b, e2e576e6-6181-4178-b989-61d0e795e559 +1NDC 0006-0277, 55154-5042, 50090-1036 +1Application NDA021995
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 dose pack | 0006-0277-02 | Merck Sharp & Dohme | 16 October 2006 |
| 2 blister pack in 1 carton / 7 tablet, film coated in 1 blister pack | 0006-0277-14 | Merck Sharp & Dohme | 12 October 2012 |
| 100 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0006-0277-28 | Merck Sharp & Dohme | 16 October 2006 |
| 30 tablet, film coated in 1 bottle | 0006-0277-31 | Merck Sharp & Dohme | 16 October 2006 |
| 30 tablet, film coated in 1 dose pack | 0006-0277-33 | Merck Sharp & Dohme | 16 October 2006 |
| 90 tablet, film coated in 1 bottle | 0006-0277-54 | Merck Sharp & Dohme | 16 October 2006 |
| 1000 tablet, film coated in 1 bottle | 0006-0277-82 | Merck Sharp & Dohme | 16 October 2006 |
| 30 tablet, film coated in 1 bottle | 50090-1036-0 | A-S Medication Solutions | 28 November 2014 |
| 90 tablet, film coated in 1 bottle | 50090-1036-2 | A-S Medication Solutions | 12 June 2018 |
| 90 tablet, film coated in 1 bottle | 50090-4084-0 | A-S Medication Solutions | 24 January 2019 |
| 1350 tablet, film coated in 1 bottle, plastic | 55154-5042-8 | Cardinal Health | 16 October 2006 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Sitagliptin 100 mg tablet.
Other strengths and forms of Sitagliptin
Clinical summary
Sitagliptin is a dipeptidyl peptidase 4 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as tablets and oral solution. MedsAcross supplies Sitagliptin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SitagliptinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- JANUVIA prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
- Januvia: European public assessment report (EPAR) · European Medicines Agency
- Ristaben: European public assessment report (EPAR) · European Medicines Agency
Need Januvia 100 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.